Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from EverQuote ( (EVER) ).
On November 3, 2025, EverQuote announced its financial results for the third quarter of 2025, highlighting a 20% year-over-year revenue growth to $173.9 million and a 63% increase in net income to $18.9 million. The company achieved record financial performance by integrating AI into its operations, which contributed to a 33% rise in adjusted EBITDA. EverQuote also executed a $21 million share buyback program, reinforcing its confidence in sustainable growth and maintaining a strong balance sheet.
The most recent analyst rating on (EVER) stock is a Hold with a $21.50 price target. To see the full list of analyst forecasts on EverQuote stock, see the EVER Stock Forecast page.
Spark’s Take on EVER Stock
According to Spark, TipRanks’ AI Analyst, EVER is a Neutral.
EverQuote’s overall score is driven by strong financial performance and positive earnings call sentiment, indicating a solid recovery and strategic growth initiatives. However, bearish technical indicators and valuation concerns moderate the score. The company’s strategic focus on AI and share repurchase program are positive signals, but competitive pressures and geographic challenges remain.
To see Spark’s full report on EVER stock, click here.
More about EverQuote
EverQuote operates a leading online marketplace for insurance shopping, connecting consumers with insurance provider customers, which includes both carriers and agents. The company focuses on being a growth partner for property and casualty insurance providers, leveraging a proprietary data and technology platform to enhance the way insurance providers attract and connect with consumers.
Average Trading Volume: 489,805
Technical Sentiment Signal: Hold
Current Market Cap: $786.5M
For an in-depth examination of EVER stock, go to TipRanks’ Overview page.